{"id":"https://openalex.org/W2018481354","doi":"https://doi.org/10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#","title":"A phase II study of constant\u2010infusion floxuridine for the treatment of metastatic renal cell carcinoma","display_name":"A phase II study of constant\u2010infusion floxuridine for the treatment of metastatic renal cell carcinoma","publication_year":1993,"publication_date":"1993-06-01","ids":{"openalex":"https://openalex.org/W2018481354","doi":"https://doi.org/10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#","mag":"2018481354","pmid":"https://pubmed.ncbi.nlm.nih.gov/8490909"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#","doi":"https://doi.org/10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113933530","display_name":"Mary J. Wilkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary J. Wilkinson","raw_affiliation_strings":["Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John W. Frye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John W. Frye","raw_affiliation_strings":["Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric J. Small","raw_affiliation_strings":["Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037875642","display_name":"Alan Paul Venook","orcid":"https://orcid.org/0000-0001-9749-6548","observed_orcids":["https://orcid.org/0000-0001-9749-6548"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan P. Venook","raw_affiliation_strings":["Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056969058","display_name":"Peter R. Carroll","orcid":"https://orcid.org/0000-0002-1086-4334","observed_orcids":["https://orcid.org/0000-0002-1086-4334","https://orcid.org/0000-0001-9659-2976"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter R. Carroll","raw_affiliation_strings":["Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111531032","display_name":"Mary Lou Ernest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Lou Ernest","raw_affiliation_strings":["Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002429484","display_name":"Robert Stagg","orcid":"https://orcid.org/0009-0009-3797-0151","observed_orcids":["https://orcid.org/0009-0009-3797-0151"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Stagg","raw_affiliation_strings":["Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Institute, Department of Urology and the Division of Clinical Pharmacy, University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":0.3834,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.63974581,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"71","issue":"11","first_page":"3601","last_page":"3604"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-fluorodeoxyuridine","display_name":"5-fluorodeoxyuridine","score":0.9750000238418579},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9649999737739563},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8930000066757202},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5419999957084656},{"id":"https://openalex.org/keywords/diarrhea-toxicity","display_name":"diarrhea toxicity","score":0.597000002861023},{"id":"https://openalex.org/keywords/tumor-response-rate","display_name":"tumor response rate","score":0.6930000185966492},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.9490000009536743}],"concepts":[{"id":"https://openalex.org/C2779598120","wikidata":"https://www.wikidata.org/wiki/Q5462356","display_name":"Floxuridine","level":4,"score":0.9054086804389954},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8294411301612854},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6534237265586853},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4879011809825897},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4712805151939392},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.4243048429489136},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3980540633201599},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3976619839668274},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32914721965789795},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.24731877446174622}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D002940","descriptor_name":"Circadian Rhythm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002940","descriptor_name":"Circadian Rhythm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002940","descriptor_name":"Circadian Rhythm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015918","descriptor_name":"Infusion Pumps, Implantable","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015918","descriptor_name":"Infusion Pumps, Implantable","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015918","descriptor_name":"Infusion Pumps, Implantable","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#","doi":"https://doi.org/10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:8490909","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8490909","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.800000011920929,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1779966086","https://openalex.org/W1822789550","https://openalex.org/W1914884493","https://openalex.org/W2010922182","https://openalex.org/W2036852386","https://openalex.org/W2247895695","https://openalex.org/W2295246435","https://openalex.org/W2395880251","https://openalex.org/W2418870571","https://openalex.org/W2731178078","https://openalex.org/W4255809853","https://openalex.org/W4388165701"],"related_works":["https://openalex.org/W2378313180","https://openalex.org/W2068743627","https://openalex.org/W4365152822","https://openalex.org/W2078453319","https://openalex.org/W2180957408","https://openalex.org/W4300080126","https://openalex.org/W4251154677","https://openalex.org/W1989873005","https://openalex.org/W2036675209","https://openalex.org/W2065179751"],"abstract_inverted_index":{"BACKGROUND:":[0],"Twenty-nine":[1],"patients":[2,54],"with":[3,11,170],"metastatic":[4,190,207],"renal":[5],"cell":[6],"carcinoma":[7],"(RCC)":[8],"were":[9,55,137,177],"treated":[10],"constant-infusion":[12],"floxuridine":[13,141,199,203],"(FUdR,":[14],"Roche":[15],"Laboratories,":[16],"Nutley,":[17],"NJ).":[18],"METHODS:":[19],"The":[20,82,179],"initial":[21],"dosage":[22,92,113,164],"was":[23,33,50,86,93,120,168,183],"0.075":[24],"mg/kg/day":[25,95,116,167],"for":[26,96],"14":[27,97],"days":[28,31,98,101,185,194],"every":[29,99],"28":[30,100],"and":[32,76,88,152,192,209],"increased":[34,146],"or":[35,117,134],"decreased":[36],"by":[37],"0.025-mg/kg/day":[38],"increments":[39],"at":[40,111],"each":[41],"subsequent":[42],"cycle":[43],"until":[44],"the":[45,89,107,187,196],"maximum":[46],"tolerated":[47,91,163],"dose":[48,147],"(MTD)":[49],"achieved.":[51],"RESULTS:":[52],"All":[53],"fully":[56],"assessable.":[57],"One":[58],"(4%)":[59],"patient":[60],"had":[61,67,73,79],"a":[62,68,112,132,211],"complete":[63,133],"response,":[64,70],"5":[65],"(17%)":[66],"partial":[69,135],"13":[71],"(50%)":[72],"stabilized":[74],"disease,":[75],"10":[77],"(34%)":[78],"progressive":[80],"disease.":[81],"treatment-limiting":[83],"toxic":[84],"effect":[85],"diarrhea,":[87],"median":[90,162,180],"0.1":[94,115],"(range,":[102],"0.05-0.275":[103],"mg/kg/day).":[104],"Five":[105],"of":[106,114,165,189,198,221,224],"six":[108],"responses":[109,176],"occurred":[110],"less,":[118],"which":[119],"achievable":[121],"in":[122],"most":[123],"patients.":[124],"Patients":[125],"who":[126],"reached":[127],"their":[128],"MTD":[129],"without":[130],"achieving":[131],"response":[136,212],"switched":[138],"to":[139,142,216,219],"circadian-infusion":[140],"determine":[143],"whether":[144,153],"an":[145],"intensity":[148],"could":[149],"be":[150,217],"administered":[151],"this":[154],"would":[155],"translate":[156],"into":[157],"additional":[158,175],"responses.":[159],"A":[160],"higher":[161],"0.15":[166],"achieved":[169],"circadian":[171,222],"administration;":[172],"however,":[173],"no":[174],"observed.":[178],"survival":[181],"time":[182],"891":[184],"after":[186,195],"diagnosis":[188],"RCC":[191,208],"445":[193],"institution":[197],"therapy.":[200],"CONCLUSIONS:":[201],"Constant-infusion":[202],"is":[204],"active":[205],"against":[206],"produces":[210],"rate":[213],"that":[214,220],"appears":[215],"comparable":[218],"administration":[223],"floxuridine.":[225]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}